Cargando…

Downregulation of m(6)A reader YTHDC2 promotes tumor progression and predicts poor prognosis in non‐small cell lung cancer

BACKGROUND: m(6)A modification affects the pathological progress of many diseases by affecting RNA stability and translocation. YTHDC2, a m(6)A reader, is associated with multiple cancers; however, little is known of its role in non‐small cell lung cancer (NSCLC). METHODS: The GEPIA, Oncomine and GE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Shulei, Han, Qiang, Liang, Maoli, Zhang, Qian, Zhang, Jing, Cao, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606000/ https://www.ncbi.nlm.nih.gov/pubmed/32956555 http://dx.doi.org/10.1111/1759-7714.13667

Ejemplares similares

Roles and mechanisms of the m(6)A reader YTHDC1 in biological processes and diseases
por: Yan, Huaqing, et al.
Publicado: (2022)

Downregulation of m(6)A Reader YTHDC2 Promotes the Proliferation and Migration of Malignant Lung Cells via CYLD/NF-κB Pathway
por: Wang, Jin, et al.
Publicado: (2021)

Pathogenic variants in the human m(6)A reader YTHDC2 are associated with primary ovarian insufficiency
por: McGlacken-Byrne, Sinéad M., et al.
Publicado: (2022)

m(6)A reader YTHDC1 modulates autophagy by targeting SQSTM1 in diabetic skin
por: Liang, Diefei, et al.
Publicado: (2021)

The m6A RNA Modification Quantity and the Prognostic Effect of Reader YTHDC2 in Colorectal Cancer
por: Liu, Tianyu, et al.
Publicado: (2022)

The m(6)A reader protein YTHDC2 interacts with the small ribosomal subunit and the 5′–3′ exoribonuclease XRN1
por: Kretschmer, Jens, et al.
Publicado: (2018)

The m6A reader YTHDC1-mediated lncRNA CTBP1-AS2 m6A modification accelerates cholangiocarcinoma progression
por: Jin, Zhe, et al.
Publicado: (2023)

Depletion of m(6)A reader protein YTHDC1 induces dilated cardiomyopathy by abnormal splicing of Titin
por: Gao, Siyun, et al.
Publicado: (2021)

The N6-methyladenosine reader protein YTHDC2 promotes gastric cancer progression via enhancing YAP mRNA translation
por: Yuan, Wei, et al.
Publicado: (2021)

The m(6)A reader YTHDC2 is essential for escape from KSHV SOX-induced RNA decay
por: Macveigh-Fierro, Daniel, et al.
Publicado: (2022)

A potassium-chloride co-transporter promotes tumor progression and castration resistance of prostate cancer through m(6)A reader YTHDC1
por: Yuan, Shuai, et al.
Publicado: (2023)

Nuclear m(6)A reader YTHDC1 regulates alternative polyadenylation and splicing during mouse oocyte development
por: Kasowitz, Seth D., et al.
Publicado: (2018)

Nuclear m6A reader YTHDC1 promotes muscle stem cell activation/proliferation by regulating mRNA splicing and nuclear export
por: Qiao, Yulong, et al.
Publicado: (2023)

Multiple Phosphorylations of SR Protein SRSF3 and Its Binding to m(6)A Reader YTHDC1 in Human Cells
por: Tatsuno, Takanori, et al.
Publicado: (2022)

The m(6)A reader YTHDC1 and the RNA helicase DDX5 control the production of rhabdomyosarcoma-enriched circRNAs
por: Dattilo, Dario, et al.
Publicado: (2023)

The m6A reader YTHDC1 regulates muscle stem cell proliferation via PI4K–Akt–mTOR signalling
por: Liu, Jin, et al.
Publicado: (2023)

The m(6)A reader YTHDC2 inhibits lung adenocarcinoma tumorigenesis by suppressing SLC7A11-dependent antioxidant function
por: Ma, Lifang, et al.
Publicado: (2020)

Nuclear Aurora kinase A switches m(6)A reader YTHDC1 to enhance an oncogenic RNA splicing of tumor suppressor RBM4
por: Li, SiSi, et al.
Publicado: (2022)

Nuclear m(6)A reader YTHDC1 regulates the scaffold function of LINE1 RNA in mouse ESCs and early embryos
por: Chen, Chuan, et al.
Publicado: (2021)

m(6)A Reader YTHDC2 Promotes Radiotherapy Resistance of Nasopharyngeal Carcinoma via Activating IGF1R/AKT/S6 Signaling Axis
por: He, Jun-Ju, et al.
Publicado: (2020)

Low expression of m6A reader YTHDC1 promotes progression of ovarian cancer via PIK3R1/STAT3/GANAB axis
por: Wang, Xiaogang, et al.
Publicado: (2023)

The Effect of N6-Methyladenosine Regulators and m6A Reader YTHDC1-Mediated N6-Methyladenosine Modification Is Involved in Oxidative Stress in Human Aortic Dissection
por: Yin, Fanxing, et al.
Publicado: (2023)

The m6A reader protein YTHDC2 is a potential biomarker and associated with immune infiltration in head and neck squamous cell carcinoma
por: Li, Yang, et al.
Publicado: (2020)

Correction to: Nuclear m6A reader YTHDC1 regulates the scaffold function of LINE1 RNA in mouse ESCs and early embryos
por: Chen, Chuan, et al.
Publicado: (2021)

N(6)-methyladenosine reader protein YTHDC1 regulates influenza A virus NS segment splicing and replication
por: Zhu, Yinxing, et al.
Publicado: (2023)

RNA N(6)-methyladenosine reader YTHDC1 is essential for TGF-beta-mediated metastasis of triple negative breast cancer
por: Tan, Brandon, et al.
Publicado: (2022)

The RNA m6A-Binding Protein YTHDC1 Is Downregulated and Associated With M2 Macrophage Infiltration in Muscle-Invasive Bladder Cancer
por: Zhao, Lamei, et al.
Publicado: (2023)

YTHDC1 mediates nuclear export of N(6)-methyladenosine methylated mRNAs
por: Roundtree, Ian A, et al.
Publicado: (2017)

YTHDC2 control of gametogenesis requires helicase activity but not m(6)A binding
por: Saito, Yuhki, et al.
Publicado: (2022)

m(6)A in mRNA coding regions promotes translation via the RNA helicase-containing YTHDC2
por: Mao, Yuanhui, et al.
Publicado: (2019)

lncRNA ZNRD1-AS1 promotes malignant lung cell proliferation, migration, and angiogenesis via the miR-942/TNS1 axis and is positively regulated by the m(6)A reader YTHDC2
por: Wang, Jin, et al.
Publicado: (2022)

YTHDC2-mediated m6A mRNA modification of Id3 suppresses cisplatin resistance in non-small cell lung cancer
por: Wang, Xifan, et al.
Publicado: (2023)

Downregulation of SIRT6 is associated with poor prognosis in patients with non-small cell lung cancer
por: Zhu, Bojin, et al.
Publicado: (2018)

YTHDC2 inhibits rat bone mesenchymal stem cells osteogenic differentiation by accelerating RUNX2 mRNA degradation via m6A methylation
por: Ma, Bo, et al.
Publicado: (2023)

m(6)A Reader: Epitranscriptome Target Prediction and Functional Characterization of N(6)-Methyladenosine (m(6)A) Readers
por: Zhen, Di, et al.
Publicado: (2020)

YTHDC2-Mediated circYTHDC2 N6-Methyladenosine Modification Promotes Vascular Smooth Muscle Cells Dysfunction Through Inhibiting Ten-Eleven Translocation 2
por: Yuan, Jun, et al.
Publicado: (2021)

Downregulation of miR-484 is associated with poor prognosis and tumor progression of gastric cancer
por: Li, Ying, et al.
Publicado: (2020)

Structural effects of m(6)A modification of the Xist A-repeat AUCG tetraloop and its recognition by YTHDC1
por: Jones, Alisha N, et al.
Publicado: (2022)

Overexpression of m6A-factors METTL3, ALKBH5, and YTHDC1 alters HPV16 mRNA splicing
por: Cui, Xiaoxu, et al.
Publicado: (2022)

YTHDC1 mitigates ischemic stroke by promoting Akt phosphorylation through destabilizing PTEN mRNA
por: Zhang, Zhaolong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3fq45q8rucev277cju3eab2bp5